Sign in
Home
Biotech News
Conferences
Technology Conferences
Biotech Conferences
CoronaVirus
Precision Vaccinations
Internet News
Research
Reverse Splits
Reverse Split News
Reverse Split Watch List
Reverse Stock Split List
Upcoming Reverse Stock Split List
More Finance Channels
Beverage Stocks
Blockchain Stocks
Gold Stocks
Marijuana Stocks
Psychedelic Stocks
Stand Down – Wall Street Bears
Tiki Hut Fund
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Thursday, May 2, 2024
Sign in / Join
Contact Us
Featured News
Free Weekly Newsletter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Internet | Biotech Stock Review
Home
Biotech News
Conferences
Technology Conferences
Biotech Conferences
CoronaVirus
Precision Vaccinations
Internet News
Research
Reverse Splits
Reverse Split News
Reverse Split Watch List
Reverse Stock Split List
Upcoming Reverse Stock Split List
More Finance Channels
Beverage Stocks
Blockchain Stocks
Gold Stocks
Marijuana Stocks
Psychedelic Stocks
Stand Down – Wall Street Bears
Tiki Hut Fund
Home
2019
July
Monthly Archives: July 2019
Featured
$230 Million Blank Check! As in blank.
Editor / Curator
-
July 17, 2019
Internet News
Forget Global Warming. Worry About Global Click Farms.
Editor / Curator
-
July 17, 2019
Israel
A New Stock Exchange for Israeli Tech Companies, Backed by NYSE.
Editor / Curator
-
July 16, 2019
Research
Duos Technologies (DOUT) $0.70. Artificial Intelligence Made Easy. Grossly Undervalued.
Editor / Curator
-
July 15, 2019
All News
MySize (MYSZ) CEO Ron Luzon. Interview. (Bloomberg)
Editor / Curator
-
July 11, 2019
Biotech News
Biotech Stock Review Adds NanoVibronix (NAOV) $2.95, to Watch List.
Editor / Curator
-
July 9, 2019
Israel
Israeli Tech Stocks Raise $165 Million on Toronto TSX, Bypassing NASDAQ.
Editor / Curator
-
July 1, 2019
1
2
Page 2 of 2
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
Institutional Analyst Newsletter
Editor / Curator
-
May 2, 2024
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
2024 Watch List
Editor / Curator
-
April 29, 2024
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
2024 Watch List
Editor / Curator
-
April 27, 2024
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
Edit with Live CSS